BPS804 + Placebo
Phase 2Withdrawn 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chronic-kidney Disease Stage 5D on Stable Hemodialysis
Conditions
Chronic-kidney Disease Stage 5D on Stable Hemodialysis
Trial Timeline
Aug 1, 2013 → Apr 1, 2014
NCT ID
NCT01806610About BPS804 + Placebo
BPS804 + Placebo is a phase 2 stage product being developed by Novartis for Chronic-kidney Disease Stage 5D on Stable Hemodialysis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT01806610. Target conditions include Chronic-kidney Disease Stage 5D on Stable Hemodialysis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01806610 | Phase 2 | Withdrawn |